森下仁丹株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Morishita Taizansha Co., Ltd.
Asset-management company of Yushi Morishita |
1,095,200 | 26.80% | ¥2.4B | ¥71.2M |
| 2 | Rohto Pharmaceutical Co., Ltd. | 355,000 | 8.60% | ¥790M | ¥23.1M |
| 3 | 公益財団法人森下仁丹奨学会 | 211,200 | 5.10% | ¥470M | ¥13.7M |
| 4 | 株式会社三菱UFJ銀行 | 132,000 | 3.20% | ¥294M | ¥8.6M |
| 5 | 日本生命保険相互会社 | 111,000 | 2.70% | ¥247M | ¥7.2M |
| 6 | 株式会社ラクサン | 106,400 | 2.60% | ¥237M | ¥6.9M |
| 7 | 株式会社徳島大正銀行 | 88,000 | 2.10% | ¥196M | ¥5.7M |
| 8 | 森下仁丹取引先持株会 | 65,200 | 1.50% | ¥145M | ¥4.2M |
| 9 | 三菱UFJ信託銀行株式会社 | 51,000 | 1.20% | ¥114M | ¥3.3M |
| 10 | ピップ株式会社 | 43,200 | 1.00% | ¥96.2M | ¥2.8M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Yushi Morishita | President & Representative Director | 30,000 | ¥66.8M | — |
| 吉田 秀章 | Director | 5,000 | ¥11.1M | — |
| 末川 久幸 | Director | — | — | — |
| 河﨑 保徳 | Director | — | — | — |
| 大城 広明 | Director | — | — | — |
| 石原 真弓 | Director | — | — | — |
| 石黒 訓 | Director | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥2,226 | ¥153.53 | 14.5x | ¥65.0 | 4,150,000 |
| FY ending Mar 2025 | ¥2,114 | ¥133.78 | 15.8x | ¥55.0 | 4,150,000 |
| FY ending Mar 2024 | ¥2,475 | ¥170.68 | 14.5x | ¥50.0 | 4,150,000 |
| FY ending Mar 2023 | ¥1,989 | ¥120.55 | 16.5x | ¥40.0 | 4,150,000 |
| FY ending Mar 2022 | ¥1,886 | ¥69.58 | 27.1x | ¥37.5 | 4,150,000 |
| FY ending Mar 2021 | ¥2,007 | ¥50.69 | 39.6x | ¥37.5 | 4,150,000 |